Antibiotic prescribing across age groups in the Kaiser Permanente Northern California population in association with different diagnoses, and with influenza incidence, 2010-2018.
Antibiotics
adults
children
ear infection
influenza
respiratory illness
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
24 02 2022
24 02 2022
Historique:
entrez:
4
5
2022
pubmed:
5
5
2022
medline:
6
5
2022
Statut:
epublish
Résumé
There is limited information on the volume of antibiotic prescribing that is influenza-associated, resulting from influenza infections and their complications (such as streptococcal pharyngitis and otitis media). Here, we estimated age/diagnosis-specific proportions of antibiotic prescriptions (fills) for the Kaiser Permanente Northern California population during 2010-2018 that were influenza-associated. The proportion of influenza-associated antibiotic prescribing among all antibiotic prescribing was higher in children aged 5-17 years compared to children aged under 5 years, ranging from 1.4% [95% CI (0.7-2.1)] in aged <1 year to 2.7% (1.9-3.4) in aged 15-17 years. For adults aged over 20 years, the proportion of influenza-associated antibiotic prescribing among all antibiotic prescribing was lower, ranging from 0.7% (0.5-1) for aged 25-29 years to 1.6% (1.2-1.9) for aged 60-64 years. Most of the influenza-associated antibiotic prescribing in children aged under 10 years was for ear infections, while for age groups over 25 years, 45-84% of influenza-associated antibiotic prescribing was for respiratory diagnoses without a bacterial indication. This suggests a modest benefit of increasing influenza vaccination coverage for reducing antibiotic prescribing, as well as the potential benefit of other measures to reduce unnecessary antibiotic prescribing for respiratory diagnoses with no bacterial indication in persons aged over 25 years, both of which may further contribute to the mitigation of antimicrobial resistance.
Identifiants
pubmed: 35506177
doi: 10.1017/S0950268822000371
pii: S0950268822000371
pmc: PMC9074113
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e85Références
JAMA Netw Open. 2018 Jun 1;1(2):e180243
pubmed: 30646067
N Engl J Med. 1999 Jan 28;340(4):260-4
pubmed: 9920949
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12896-12901
pubmed: 30559195
Clin Infect Dis. 2021 Jun 15;72(12):2144-2153
pubmed: 32270199
J Am Med Inform Assoc. 2015 Sep;22(5):957-61
pubmed: 26078413
Perm J. 2012 Spring;16(2):15-21
pubmed: 22745611
Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):15798-803
pubmed: 25331901
Perm J. 2016 Fall;20(4):15-225
pubmed: 27548806
Clin Infect Dis. 2016 Jul 1;63(1):21-32
pubmed: 27025838
Vaccine. 2007 Feb 19;25(9):1683-9
pubmed: 17156899
Epidemiology. 2012 Nov;23(6):829-38
pubmed: 22992574
EGEMS (Wash DC). 2014 Mar 24;2(1):1049
pubmed: 25848584
JAMA. 2016 May 3;315(17):1864-73
pubmed: 27139059
Am J Epidemiol. 1985 Jun;121(6):811-22
pubmed: 4014174
Am J Epidemiol. 2014 Jan 15;179(2):156-67
pubmed: 24190951
Emerg Infect Dis. 2020 Jan;26(1):138-142
pubmed: 31574242
Pediatr Infect Dis J. 2020 Jan;39(1):e1-e10
pubmed: 31725115
PLoS Med. 2020 Aug 19;17(8):e1003208
pubmed: 32813708
Ann Intern Med. 2017 Jun 06;166(11):765-774
pubmed: 28492914
Int J Antimicrob Agents. 2021 Jun;57(6):106339
pubmed: 33852933